Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Persistence with generic imatinib for chronic myeloid leukemia: a matched cohort study.

Klil-Drori AJ, Yin H, Azoulay L, Harnois M, Gratton MO, Busque L, Assouline SE; Groupe Québécois de Recherche en Leucémie Myéloïde Chronique et Néoplasies Myéloprolifératives (GQR LMC-NMP).

Haematologica. 2019 Jul;104(7):e293-e295. doi: 10.3324/haematol.2018.211235. Epub 2019 Jan 10. No abstract available.

2.

The Use of a Water Soluble Flexible Substrate to Embed Electronics in Additively Manufactured Objects: From Tattoo to Water Transfer Printed Electronics.

Le Borgne B, Jacques E, Harnois M.

Micromachines (Basel). 2018 Sep 17;9(9). pii: E474. doi: 10.3390/mi9090474.

3.

Molecular monitoring of therapeutic milestones and clinical outcomes in patients with chronic myeloid leukemia.

Klil-Drori AJ, Yin H, Azoulay L, Del Corpo A, Harnois M, Gratton MO, Olney HJ, Delage R, Laneuville P, Mollica L, Busque L, Assouline SE; Groupe Québécois de Recherche en Leucémie Myéloïde Chronique et Néoplasies Myéloprolifératives (GQR LMC-NMP).

Cancer. 2019 Feb 15;125(4):618-625. doi: 10.1002/cncr.31835. Epub 2018 Nov 13.

PMID:
30423211
4.

Direct Integration of Red-NIR Emissive Ceramic-like An M6 Xi8 Xa6 Metal Cluster Salts in Organic Copolymers Using Supramolecular Interactions.

Robin M, Dumait N, Amela-Cortes M, Roiland C, Harnois M, Jacques E, Folliot H, Molard Y.

Chemistry. 2018 Apr 3;24(19):4825-4829. doi: 10.1002/chem.201800860. Epub 2018 Mar 13.

PMID:
29470849
5.

A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification.

Angevin E, Spitaleri G, Rodon J, Dotti K, Isambert N, Salvagni S, Moreno V, Assadourian S, Gomez C, Harnois M, Hollebecque A, Azaro A, Hervieu A, Rihawi K, De Marinis F.

Eur J Cancer. 2017 Dec;87:131-139. doi: 10.1016/j.ejca.2017.10.016. Epub 2017 Nov 14.

6.

Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer.

Shitara K, Kim TM, Yokota T, Goto M, Satoh T, Ahn JH, Kim HS, Assadourian S, Gomez C, Harnois M, Hamauchi S, Kudo T, Doi T, Bang YJ.

Oncotarget. 2017 Jun 16;8(45):79546-79555. doi: 10.18632/oncotarget.18554. eCollection 2017 Oct 3.

7.

Conformal Electronics Wrapped Around Daily Life Objects Using an Original Method: Water Transfer Printing.

Le Borgne B, De Sagazan O, Crand S, Jacques E, Harnois M.

ACS Appl Mater Interfaces. 2017 Sep 6;9(35):29424-29429. doi: 10.1021/acsami.7b07327. Epub 2017 Aug 25.

PMID:
28831803
8.

Early switch to second-line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response.

Klil-Drori AJ, Yin H, Azoulay L, Harnois M, Gratton MO, Del Corpo A, Olney HJ, Delage R, Laneuville P, Mollica L, Busque L, Assouline SE; Quebec CML Group.

Am J Hematol. 2017 Oct;92(10):E602-E604. doi: 10.1002/ajh.24838. Epub 2017 Jul 29. No abstract available.

9.

Epoxy Based Ink as Versatile Material for Inkjet-Printed Devices.

Robin M, Kuai W, Amela-Cortes M, Cordier S, Molard Y, Mohammed-Brahim T, Jacques E, Harnois M.

ACS Appl Mater Interfaces. 2015 Oct 7;7(39):21975-84. doi: 10.1021/acsami.5b06678. Epub 2015 Sep 22.

PMID:
26372334
10.

Impaired interferon-alpha production by plasmacytoid dendritic cells after cord blood transplantation in children: implication for post-transplantation toll-like receptor ligand-based immunotherapy.

Charrier E, Cordeiro P, Brito RM, Harnois M, Mezziani S, Herblot S, Le Deist F, Duval M.

Biol Blood Marrow Transplant. 2014 Oct;20(10):1501-7. doi: 10.1016/j.bbmt.2014.06.007. Epub 2014 Aug 14.

11.

Split and flow: reconfigurable capillary connection for digital microfluidic devices.

Lapierre F, Harnois M, Coffinier Y, Boukherroub R, Thomy V.

Lab Chip. 2014 Sep 21;14(18):3589-93. doi: 10.1039/c4lc00650j. Epub 2014 Jul 24.

PMID:
25058858
12.

Defects in CD54 and CD86 up-regulation by plasmacytoid dendritic cells during pregnancy.

Cordeau M, Herblot S, Charrier E, Audibert F, Cordeiro P, Harnois M, Duval M.

Immunol Invest. 2012;41(5):497-506. doi: 10.3109/08820139.2012.682243. Epub 2012 May 17.

PMID:
22594887
13.

Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells.

Charrier E, Cordeiro P, Cordeau M, Dardari R, Michaud A, Harnois M, Merindol N, Herblot S, Duval M.

Cell Immunol. 2012 Mar-Apr;276(1-2):114-21. doi: 10.1016/j.cellimm.2012.04.010. Epub 2012 Apr 27.

PMID:
22578600
14.

Zipping effect on omniphobic surfaces for controlled deposition of minute amounts of fluid or colloids.

Dufour R, Brunet P, Harnois M, Boukherroub R, Thomy V, Senez V.

Small. 2012 Apr 23;8(8):1229-36. doi: 10.1002/smll.201101895. Epub 2012 Feb 16.

PMID:
22337592
15.

Engineering sticky superomniphobic surfaces on transparent and flexible PDMS substrate.

Dufour R, Harnois M, Coffinier Y, Thomy V, Boukherroub R, Senez V.

Langmuir. 2010 Nov 16;26(22):17242-7. doi: 10.1021/la103462z. Epub 2010 Oct 18.

PMID:
20954730
16.

Crystal structures of two human pyrophosphorylase isoforms in complexes with UDPGlc(Gal)NAc: role of the alternatively spliced insert in the enzyme oligomeric assembly and active site architecture.

Peneff C, Ferrari P, Charrier V, Taburet Y, Monnier C, Zamboni V, Winter J, Harnois M, Fassy F, Bourne Y.

EMBO J. 2001 Nov 15;20(22):6191-202.

17.

Identification of five new genes, closely related to the interleukin-1beta converting enzyme gene, that do not encode functional proteases.

Rocher C, Faucheu C, Blanchet AM, Claudon M, Hervé F, Durand L, Harnois M, Diu-Hercend A, Lalanne JL.

Eur J Biochem. 1997 Jun 1;246(2):394-400.

18.

TCT.1, a target molecule for gamma/delta T cells, is encoded by an immunoglobulin superfamily gene (Blast-1) located in the CD1 region of human chromosome 1.

Del Porto P, Mami-Chouaib F, Bruneau JM, Jitsukawa S, Dumas J, Harnois M, Hercend T.

J Exp Med. 1991 Jun 1;173(6):1339-44.

19.

A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures.

Ishidate M Jr, Harnois MC, Sofuni T.

Mutat Res. 1988 Mar;195(2):151-213. Review.

PMID:
3277036
20.

The clastogenicity of chemicals in cultured mammalian cells.

Ishidate M Jr, Harnois MC.

Mutagenesis. 1987 May;2(3):240-3. No abstract available.

PMID:
3325752
21.

[Quality control of cell lines in the JCRB-cell bank].

Mizusawa H, Kawase M, Sasaki K, Harnois M, Ishidate M.

Tanpakushitsu Kakusan Koso. 1986 Oct;31(13):1470-80. Japanese. No abstract available.

PMID:
3809531
22.

Prevention of Down's syndrome.

Harnois MC.

Lancet. 1973 Apr 7;1(7806):771-2. No abstract available.

PMID:
4120748
23.

Virus and DNA synthesis in x-irradiated human kidney cell cultures exposed to adenovirus type 12.

Harnois M, Ho M.

Proc Soc Exp Biol Med. 1968 Jul;128(3):651-4. No abstract available.

PMID:
5668103

Supplemental Content

Loading ...
Support Center